Effects of Hospital-Community Integrated Management Based on the Joint Diagnosis and Treatment Center for Chronic Diseases in Patients with Type 2 Diabetes Mellitus
Fei Yang,Yu Shaochu,Sun Liqin,Yuan Chungang,Lou Qinhua,Jiang Min,Zhang Fangying,Dong Fengqin
DOI: https://doi.org/10.3877/cma.j.issn.1674-6880.2017.03.007
2017-01-01
Abstract:Objective To study the clinical effects of hospital-community integrated management based on the joint center of diagnosis and treatment for chronic disease in patients with type 2 diabetes mellitus. Methods A total of 122 type 2 diabetes mellitus patients were randomly divided into the control group (n=62) and treatment group (n=60). Patients in the treatment group were managed by the joint diagnosis and treatment center for chronic disease after they were established management files, while patients in the control group were managed according to the previous diabetes management mode. The levels of glycated hemoglobin (HbA1c), fasting blood glucose, 2 h postprandial blood glucose, blood pressure, blood lipid, urine microalbumin/createnine and body mass index (BMI) were detected. And the standard reaching rate of above indicators were compared between before and 24 months after the management. Results The levels of HbA1c [(6.6 ± 3.0)% vs. (7.7 ± 1.4)%, t=2.792, P=0.031], fasting blood glucose [(6.7 ± 1.2) mmol/L vs. (8.4 ± 2.4) mmol/L, t=5.134, P=0.005], 2 h postprandial blood glucose [(9.5 ± 2.3) mmol/L vs. (11.0 ± 2.8) mmol/L, t=3.286, P=0.008] and total cholesterol [(5.1 ± 1.4) mmol / L vs. (5.9 ± 1.9) mmol / L, t = 2.527, P = 0.012] in the treatment group before the management were much lower than those after the management, and the standard reaching rate of HbA1c (47/60 vs. 33/60, χ2=7.350, P=0.007), fasting blood glucose (49/60 vs. 39/60, χ2=4.261, P=0.039), 2 h postprandial blood glucose (49/60 vs. 29/60, χ2 = 14.650, P<0.001), blood pressure (45/60 vs. 33/60, χ2=5.167, P=0.038) and triglyceride (33/60 vs. 21/60, χ2=4.089, P=0.044) in the treatment group before the management were much higher than those after the management. However, the above indicators in the control group all showed no significant differences between before and 24 months after the management (all P<0.05). Conclusion The therapeutic effect of hospital-community integrated management based on the joint diagnosis and treatment center for chronic disease in patients with type 2 diabetes mellitus is remarkable.